Phyto-Riker plans to provide free HIV drugs throughout sub-Saharan Africa.

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.304, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A missing piece in the puzzle: HIV in mature adults in sub-Saharan Africa

By Mutevedzi Portia C   Newell Marie-Louise  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 755-767

Future Medicine

Access to resources Recommend Favorite

The Economics of HIV Vaccines: Projecting the Impact of HIV Vaccination of Infants in Sub-Saharan Africa

By Bos J.M.   Postma M.J.  

PharmacoEconomics, Vol. 19, Iss. 9, 2001-01 ,pp. : 937-946

Adis International

Access to resources Recommend Favorite

Disclosure of maternal HIV status to children: considerations for research and practice in sub-Saharan Africa

By Mkwanazi Ntombizodumo B   Rochat Tamsen J   Imrie John   Bland Ruth M  

Future Virology, Vol. 7, Iss. 12, 2012-12 ,pp. : 1159-1182

Future Medicine

Access to resources Recommend Favorite

Implementing adolescent HPV vax in sub-Saharan Africa

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Nevirapine prophylaxis cost effective in sub-Saharan Africa

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite